• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
50 Studies Every Vascular Surgeon Should Know

50 Studies Every Vascular Surgeon Should Know

350.92 zł
315.83 zł Save 35.09 zł
Lowest price within 30 days before promotion: 315.83 zł
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

50 Studies every Vascular Surgeon Should Know presents key studies that have shaped the practice of Vascular Surgery. Selected using a rigorous methodology, the studies cover topics including carotid artery disease, aortic aneurysm, peripheral artery disease, trauma, venous disease and vascular access. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implication for practice. An illustrative clinical case concludes each review to highlight the impact of the study on clinical practice. This book is a must read for vascular surgeons, especially those in training and preparing for board exams, as well as anyone who wants to learn more about the data behind clinical practice.
Product Details

Data sheet

Publication date
Issue number
Pages count
Dimensions (mm)
156 x 235
Weight (g)
  • Section 1: Secondary Prevention in Peripheral Arterial Disease; Julien Al Shakarchi and Andrew Garnham; 1. Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE): A Randomized, Blinded Trial; 2. Rivaroxaban With or Without Aspirin in Patients with Stable Peripheral or Carotid Artery Disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS), an International, Randomized, Double-Blind, Placebo-Controlled Trial; 3. Rivaroxaban in Peripheral Artery Disease After Revascularization (VOYAGER); 4. UK Medical Research Council/British Heart Foundation Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomized Placebo-Controlled Trial; 5. Systematic Review of the Efficacy of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication; Section 2: Cerebrovascular Disease; Julien Al Shakarchi and Alok Tiwari; 6. Analysis of Pooled Data from the Randomized Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis; 7. Early Endarterectomy Carries a Lower Procedural Risk Than Early Stenting in Patients with Symptomatic Stenosis of the Internal Carotid Artery; 8. Prevention of Disabling and Fatal Strokes by Successful Carotid Endarterectomy in Patients Without Recent Neurologic Symptoms: First Asymptomatic Carotid Surgery Trial (ACST-1), a Randomized Controlled Trial; 9. Safety of Stenting and Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Meta-analysis of Randomized Controlled Trials; 10. Second Asymptomatic Carotid Surgery Trial (ACST-2): A Randomized Comparison of Carotid Artery Stenting Versus Carotid Endarterectomy; 11. General Anesthesia Versus Local Anesthesia for Carotid Surgery (GALA): A Multicenter, Randomized Controlled Trial; 12. Prospective Randomized Trial of Carotid Endarterectomy with Primary Closure and Patch Angioplasty with Saphenous Vein, Jugular Vein, and Polytetrafluoroethylene: Long-Term Follow-up; Section 3: Thoracic Outlet; Julien Al Shakarchi and Andrew Garnham; 13. A Decade of Excellent Outcomes After Surgical Intervention in 538 Patients with Thoracic Outlet Syndrome; 14. A Systematic Review and Meta-Analysis for the Management of Paget–Schroetter Syndrome; Section 4: Thoracic Aortic Disease; Julien Al Shakarchi and Donald Adam; 15. Randomized Comparison of Strategies for Type B Aortic Dissection: The Investigation of Stent Grafts in Aortic Dissection (INSTEAD) Trial; 16. Outcomes of 3,309 Thoracoabdominal Aortic Aneurysm Repairs; 17. Long-Term Results of Endovascular Repair for Descending Thoracic Aortic Aneurysms; Section 5: Abdominal Aortic Disease; Julien Al Shakarchi; 18. Multicenter Aneurysm Screening Study (MASS): Cost-Effectiveness Analysis of Screening for Abdominal Aortic Aneurysms Based on 4-Year Results from a Randomized Controlled Trial; 19. Long-Term Outcomes of Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysms: United Kingdom Small Aneurysm Trial (UKSAT); 20. Endovascular Repair Compared with Surveillance for Patients with Small Abdominal Aortic Aneurysms: Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL) Trial; 21. Endovascular Versus Open Repair of Abdominal Aortic Aneurysm in 15 Years Follow-up of the UK Endovascular Aneurysm Repair Trial 1 (EVAR 1): A Randomized Controlled Trial; 22. Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair (EVAR 2); 23. Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (OVER); 24. Endovascular or Open Repair Strategy for Ruptured Abdominal Aortic Aneurysm: 30-Day Outcomes from the Immediate Management of Patients with Rupture: Open Versus Endovascular Repair (IMPROVE) Randomized Trial; 25. Meta-analysis of Fenestrated Endovascular Aneurysm Repair Versus Open Surgical Repair of Juxtarenal Abdominal Aortic Aneurysms; Section 6: Visceral and Renal Arterial Disease; Julien Al Shakarchi and Richard Downing; 26. Stenting and Medical Therapy for Atherosclerotic Renal Artery Stenosis: The Cardiovascular Outcomes in Renal Atherosclerotic Lesion (CORAL) Trial; 27. Patient Survival After Open and Endovascular Mesenteric Revascularization for Chronic Mesenteric Ischemia; 28. Splenic Artery Aneurysms: Two Decades of Experience at the Mayo Clinic; 29. Renal Artery Aneurysms: A 35-Year Clinical Experience with 252 Aneurysms in 168 Patients; 30. Open and Laparoscopic Treatment of Median Arcuate Ligament Syndrome; Section 7: Peripheral Arterial Disease; Julien Al Shakarchi and Lewis Meecham; 31. Supervised Exercise Versus Primary Stenting for Claudication Resulting from Aortoiliac Peripheral Artery Disease: The Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study; 32. Absence of Long-Term Benefit of Revascularization in Patients with Intermittent Claudication: The Invasive Revascularization or Not in Intermittent Claudication (IRONIC) Study; 33. Autologous Saphenous Vein and Expanded Polytetrafluoroethylene Grafts in Infra-inguinal Arterial Reconstructions: A 6-Year Prospective Multicenter Randomized Comparison; 34. Bypass Versus Angioplasty in Severe Ischemia of the Leg (BASIL): A Multicenter, Randomized Controlled Trial; 35. Is Duplex Surveillance of Value After Leg Vein Bypass Grafting? Principal Results of the Vein Graft Surveillance Randomized Trial (VGST); 36. Dutch Iliac Stent Trial: Long-Term Results in Patients Randomized for Primary or Selective Stent Placement; 37. Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-analysis of Randomized Controlled Trials; 38. Meta-analysis of Open and Endovascular Repair of Popliteal Artery Aneurysms; 39. A Prospective Study of Risk Factors for Diabetic Foot Ulcer; Section 8: Venous Disease; Julien Al Shakarchi and Isaac Nyamekye; 40. Long-Term Outcome After Additional Catheter-Directed Thrombolysis Versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (the CaVenT Study): A Randomized Controlled Trial; 41. Pharmacomechanical Catheter-Directed Thrombolysis for Deep Vein Thrombosis: The Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) Trial; 42. Long-Term Results of Compression Therapy Alone Versus Compression Plus Surgery in Chronic Venous Ulceration: The Effect of Surgery and Compression on Healing and Recurrence (ESCHAR) Study, a Randomized Controlled Trial; 43. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration: The Early Venous Reflux Ablation (EVRA) Trial; 44. 5-Year Outcomes of a Randomized Trial of Treatments for Varicose Veins: The Comparison of Laser, Surgery, and Foam Sclerotherapy (CLASS) Trial; 45. Comparison of Endovenous Ablation Techniques, Foam Sclerotherapy, and Surgical Stripping for Great Saphenous Varicose Veins: Extended 5-Year Follow-up of a Randomized Controlled Trial; 46. 2-Year Results of a Multicenter Randomized Controlled Trial Comparing Mechanochemical Endovenous Ablation to Radiofrequency Ablation in the Treatment of Primary Great Saphenous Vein Incompetence: The MARADONA Trial; Section 9: Vascular Access; Julien Al Shakarchi and Nicholas Inston; 47. Multiple Preoperative and Intraoperative Factors Predict Early Fistula Thrombosis: The Hemodialysis Fistula Maturation (HFM) Study; 48. Long-Term Functional Patency and Cost-Effectiveness of Arteriovenous Fistula Creation Under Regional Anesthesia: A Randomized Controlled Trial; Section 10: Trauma; Julien Al Shakarchi and Jack Fairhead; 49. Durability of Endovascular Repair in Blunt Traumatic Thoracic Aortic Injury: Long-Term Outcome from Four Tertiary Referral Centers; 50. A Multicenter Trial of Vena Cava Filters in Severely Injured Patients;
Comments (0)